KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Current Leases: 2020-2025

Historic Current Leases for Twist Bioscience (TWST) over the last 6 years, with Sep 2025 value amounting to $13.8 million.

  • Twist Bioscience's Current Leases fell 6.64% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of $13.8 million for FY2025, which is 6.64% down from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Current Leases is $13.8 million, which was down 6.64% from $14.8 million recorded in FY2024.
  • Twist Bioscience's Current Leases' 5-year high stood at $14.9 million during FY2023, with a 5-year trough of $8.2 million in FY2021.
  • For the 3-year period, Twist Bioscience's Current Leases averaged around $14.5 million, with its median value being $14.8 million (2024).
  • Its Current Leases has fluctuated over the past 5 years, first spiked by 66.10% in 2022, then fell by 6.64% in 2025.
  • Yearly analysis of 5 years shows Twist Bioscience's Current Leases stood at $8.2 million in 2021, then skyrocketed by 66.10% to $13.6 million in 2022, then grew by 9.19% to $14.9 million in 2023, then decreased by 0.61% to $14.8 million in 2024, then declined by 6.64% to $13.8 million in 2025.